FAQ Library 

FAQ Library  published on October 9, 2015

Dr. Stuart Goldberg discusses if your patients can ever stop therapy.

For more information on managing your patients with CML, please view the activity available here.
FAQ Library  published on October 9, 2015

Dr. Stuart Goldberg discusses mutational studies and how to interpret them.

For more information on managing your patients with CML, please view the activity available here.
FAQ Library  published on October 9, 2015

Dr. Stuart Goldberg discusses the major reasons why patients fail to respond to TKI therapies.

For more information on managing your patients with CML, please view the activity available here.
FAQ Library  published on October 9, 2015

Dr. Stuart Goldberg discusses newer options for patients who fail first- and second-generation TKI therapies.

For more information on managing your patients with CML, please view the activity available here.
FAQ Library  published on October 9, 2015

Dr. Stuart Goldberg discusses the importance of the three month milestone monitoring visit.

For more information on managing your patients with CML, please view the activity available here.
FAQ Library  published on October 9, 2015

Dr. Stuart Goldberg explains the Sokal score and why it is important in CML.

For more information on managing your patients with CML, please view the activity available here.
FAQ Library  published on October 9, 2015

Dr. Stuart Goldberg discusses the importance of adherence to TKI therapies.

For more information on managing your patients with CML, please view the activity available here.
FAQ Library  published on June 10, 2015
Dr. Karen Seiter discusses the efficacy and safety considerations in using ponatinib.
FAQ Library  published on May 6, 2015
Dr. Karen Seiter discusses the most common reasons for treatment failure.
FAQ Library  published on April 9, 2015
Dr. Karen Seiter discusses using second-generation TKIs as a first-line approach.
Page 1 of 3
Results 1 - 10 of 23